TY - JOUR
T1 - The effect of mirabegron on energy expenditure and brown adipose tissue in healthy lean South Asian and Europid men
AU - Nahon, Kimberly J.
AU - Janssen, Laura G. M.
AU - Sardjoe Mishre, Aashley S. D.
AU - Bilsen, Manu P.
AU - van der Eijk, Jari A.
AU - Botani, Kani
AU - Overduin, Lisanne A.
AU - Ruiz, Jonatan R.
AU - Burakiewicz, Jedrzej
AU - Dzyubachyk, Oleh
AU - Webb, Andrew G.
AU - Kan, Hermien E.
AU - Berbée, Jimmy F. P.
AU - van Klinken, Jan-Bert
AU - van Dijk, Ko Willems
AU - van Weeghel, Michel
AU - Vaz, Frédéric M.
AU - Coskun, Tamer
AU - Jazet, Ingrid M.
AU - Kooijman, Sander
AU - Martinez-Tellez, Borja
AU - Boon, Mariëtte R.
AU - Rensen, Patrick C. N.
PY - 2020/11
Y1 - 2020/11
N2 - Aim: To compare the effects of cold exposure and the β3-adrenergic receptor agonist mirabegron on plasma lipids, energy expenditure and brown adipose tissue (BAT) activity in South Asians versus Europids. Materials and Methods: Ten lean Dutch South Asian (aged 18-30 years; body mass index [BMI] 18-25 kg/m2) and 10 age- and BMI-matched Europid men participated in a randomized, double-blinded, cross-over study consisting of three interventions: short-term (~ 2 hours) cold exposure, mirabegron (200 mg one dose p.o.) and placebo. Before and after each intervention, we performed lipidomic analysis in serum, assessed resting energy expenditure (REE) and skin temperature, and measured BAT fat fraction by magnetic resonance imaging. Results: In both ethnicities, cold exposure increased the levels of several serum lipid species, whereas mirabegron only increased free fatty acids. Cold exposure increased lipid oxidation in both ethnicities, while mirabegron increased lipid oxidation in Europids only. Cold exposure and mirabegron enhanced supraclavicular skin temperature in both ethnicities. Cold exposure decreased BAT fat fraction in both ethnicities. After the combination of data from both ethnicities, mirabegron decreased BAT fat fraction compared with placebo. Conclusions: In South Asians and Europids, cold exposure and mirabegron induced beneficial metabolic effects. When combining both ethnicities, cold exposure and mirabegron increased REE and lipid oxidation, coinciding with a higher supraclavicular skin temperature and lower BAT fat fraction.
AB - Aim: To compare the effects of cold exposure and the β3-adrenergic receptor agonist mirabegron on plasma lipids, energy expenditure and brown adipose tissue (BAT) activity in South Asians versus Europids. Materials and Methods: Ten lean Dutch South Asian (aged 18-30 years; body mass index [BMI] 18-25 kg/m2) and 10 age- and BMI-matched Europid men participated in a randomized, double-blinded, cross-over study consisting of three interventions: short-term (~ 2 hours) cold exposure, mirabegron (200 mg one dose p.o.) and placebo. Before and after each intervention, we performed lipidomic analysis in serum, assessed resting energy expenditure (REE) and skin temperature, and measured BAT fat fraction by magnetic resonance imaging. Results: In both ethnicities, cold exposure increased the levels of several serum lipid species, whereas mirabegron only increased free fatty acids. Cold exposure increased lipid oxidation in both ethnicities, while mirabegron increased lipid oxidation in Europids only. Cold exposure and mirabegron enhanced supraclavicular skin temperature in both ethnicities. Cold exposure decreased BAT fat fraction in both ethnicities. After the combination of data from both ethnicities, mirabegron decreased BAT fat fraction compared with placebo. Conclusions: In South Asians and Europids, cold exposure and mirabegron induced beneficial metabolic effects. When combining both ethnicities, cold exposure and mirabegron increased REE and lipid oxidation, coinciding with a higher supraclavicular skin temperature and lower BAT fat fraction.
KW - South Asian
KW - brown adipose tissue
KW - energy expenditure
KW - lipid metabolism
KW - metabolic disease
KW - mirabegron
UR - http://www.scopus.com/inward/record.url?scp=85088654545&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/dom.14120
DO - https://doi.org/10.1111/dom.14120
M3 - Article
C2 - 32558052
SN - 1462-8902
VL - 22
SP - 2032
EP - 2044
JO - Diabetes, obesity & metabolism
JF - Diabetes, obesity & metabolism
IS - 11
ER -